NCT06499415View on ClinicalTrials.gov

Combination Therapy of 5-Fluorouracil and CALcipotriol Versus 5-Fluorouracil in the Treatment of Actinic Keratosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

232

Participants

Timeline

Start Date

September 4, 2024

Primary Completion Date

March 2, 2029

Study Completion Date

March 2, 2029

Conditions
Actinic Keratoses
Interventions
DRUG

5FU-Calcipotriol

topical 5FU-CAL, twice daily, during 4 or 6 consecutive days, depending on the treatment location

DRUG

5-FU 50 MG/ML Topical Cream

topical 5FU, twice daily, 7 days a week, during 4 weeks

Trial Locations (4)

6419 HC

RECRUITING

Zuyderland Medical Center, Heerlen

6229 HX

RECRUITING

Maastricht University Medical Center, Maastricht

5912 BL

RECRUITING

VieCuri Medical Center, Venlo

5623 EJ

RECRUITING

Catharina Hospital Eindhoven, Eindhoven

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER